A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma

Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
56 days
Participants
15
Age Range
28-57 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Study Summary
Sign in to read for free